1. Identification of Angiogenesis/Metastases Genes Predicting Chemoradiotherapy Response in Patients With Laryngopharyngeal Carcinoma
   Ian Ganly et al, 2007, Journal of Clinical Oncology CrossRef
2. Mechanism of Competition between Nutlin3 and p53 for Binding with Mdm2
   Shu-Xia Liu et al, 2017, Chinese Physics Letters CrossRef
3. Inhibition of the p53-MDM2 Interaction: Targeting a Protein-Protein Interface
   Patrick Chène, 2004, Molecular Cancer Research CrossRef
4. MDM2 and Its Splice Variant Messenger RNAs: Expression in Tumors and Down-Regulation Using Antisense Oligonucleotides
   Frank Bartel et al, 2004, Molecular Cancer Research CrossRef
5. Identifying driver genomic alterations in cancers by searching minimum-weight, mutually exclusive sets
   Songjian Lu et al, 2015, 2015 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) CrossRef
6. Alteration of p53 Pathway in Squamous Cell Carcinoma of the Head and Neck: Impact on Treatment Outcome in Patients Treated With Larynx Preservation Intent
   Iman Osman et al, 2002, Journal of Clinical Oncology CrossRef
7. Benzodiazepinedione inhibitors of the Hdm2:p53 complex suppress human tumor cell proliferation in vitro and sensitize tumors to doxorubicin in vivo
   Holly K. Koblish et al, 2006, Molecular Cancer Therapeutics CrossRef
8. Curcumin, a Dietary Component, Has Anticancer, Chemosensitization, and Radiosensitization Effects by Down-regulating the MDM2 Oncogene through the PI3K/mTOR/ETS2 Pathway
   Mao Li et al, 2007, Cancer Research CrossRef
9. Radiosensitization by Antisense Anti-MDM2 Mixed-Backbone Oligonucleotide in in Vitro and in Vivo Human Cancer Models
   Zhuo Zhang et al, 2004, Clinical Cancer Research CrossRef